Aurora Therapeutics
13 employees on LinkedIn · 1 known investors
Find your way into Aurora Therapeutics
Sign up to see every warm intro you have to Aurora Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aurora Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aurora develops a platform for personalized gene editing to treat rare genetic diseases at scale. The company targets patients with rare disease variants by systematizing and scaling gene editing treatments to address genetic mutations that lack existing therapeutic options.
Investors · 1
How we know: Menlo Ventures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$16M disclosed across 1 round · 2026
- $16MSeedFeb 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 3
Companies working in the same space as Aurora Therapeutics.
Frequently asked questions
- What does Aurora Therapeutics do?
- Aurora develops a platform for personalized gene editing to treat rare genetic diseases at scale. The company targets patients with rare disease variants by systematizing and scaling gene editing treatments to address genetic mutations that lack existing therapeutic options.
- Who are Aurora Therapeutics's investors?
- Aurora Therapeutics's investors include Menlo Ventures.
- How much funding has Aurora Therapeutics raised?
- Aurora Therapeutics has disclosed $16M raised across 1 round.


